Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-49395
Mar Drugs 2020 Dec 29;191:. doi: 10.3390/md19010011.
Show Gene links Show Anatomy links

A Cytotoxic Porphyrin from North Pacific Brittle Star Ophiura sarsii.

Klimenko A , Huber R , Marcourt L , Chardonnens E , Koval A , Khotimchenko YS , Ferreira Queiroz E , Wolfender JL , Katanaev VL .


???displayArticle.abstract???
Triple-negative breast cancer (TNBC) represents the deadliest form of gynecological tumors currently lacking targeted therapies. The ethanol extract of the North Pacific brittle star Ophiura sarsii presented promising anti-TNBC activities. After elimination of the inert material, the active extract was submitted to a bioguided isolation approach using high-resolution semipreparative HPLC-UV, resulting in one-step isolation of an unusual porphyrin derivative possessing strong cytotoxic activity. HRMS and 2D NMR resulted in the structure elucidation of the compound as (3S,4S)-14-Ethyl-9-(hydroxymethyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid. Never identified before in Ophiuroidea, porphyrins have found broad applications as photosensitizers in the anticancer photodynamic therapy. The simple isolation of a cytotoxic porphyrin from an abundant brittle star species we describe here may pave the way for novel natural-based developments of targeted anti-cancer therapies.

???displayArticle.pubmedLink??? 33383654
???displayArticle.pmcLink??? PMC7824513
???displayArticle.link??? Mar Drugs
???displayArticle.grants??? [+]



???attribute.lit??? ???displayArticles.show???
References [+] :
Blagodatski, Targeting the Wnt pathways for therapies. 2014, Pubmed